Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,700 shares at $76.57 ($649K) on 2014-03-21, disclosed to the SEC on 2014-03-25.
Scheduled sale ($649k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.53 | 2,450 | $180K | 27.8% |
| 2 | $74.47 | 2,750 | $205K | 31.6% |
| 3 | $75.25 | 3,000 | $226K | 34.8% |
| 4 | $76.57 | 500 | $38K | 5.9% |
| Total | $74.59 avg | 8,700 | $649K | 100% |
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |